Vanguard Group Inc Mirum Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,496,112 shares of MIRM stock, worth $106 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,496,112
Previous 2,446,733
2.02%
Holding current value
$106 Million
Previous $83.7 Million
16.37%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MIRM
# of Institutions
183Shares Held
54.3MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$275 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$211 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$185 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$153 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$137 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.55B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...